1093064-67-5 Usage
Molecular weight
259.06 g/mol
The total mass of a single molecule of 2-(4-bromo-3-fluorophenyl)-5-methyl-1,3,4-oxadiazole is 259.06 grams per mole of the compound.
Heterocyclic aromatic compound
Oxadiazole ring
The compound has a ring structure containing both carbon and hetero atoms (in this case, nitrogen and oxygen), which gives it aromatic properties.
Presence of functional groups
Bromine, fluorine, and methyl groups
The compound contains a bromine atom at the 4-position, a fluorine atom at the 3-position, and a methyl group at the 5-position, which contribute to its chemical reactivity and properties.
Potential applications
Pharmaceutical and agrochemical industries
Due to its versatile chemical properties and potential biological activity, the compound may be used in drug discovery, as a building block in organic synthesis, or as a precursor in the development of pharmaceuticals.
Possible uses
Pesticide, herbicide, or other chemical agents
The compound could be employed as a pesticide, herbicide, or other chemical agents in the agrochemical industry.
Safety precautions
Handle and use with appropriate caution
As with any chemical, it is essential to follow proper safety guidelines and handle 2-(4-bromo-3-fluorophenyl)-5-methyl-1,3,4-oxadiazole with care to avoid potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 1093064-67-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,3,0,6 and 4 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1093064-67:
(9*1)+(8*0)+(7*9)+(6*3)+(5*0)+(4*6)+(3*4)+(2*6)+(1*7)=145
145 % 10 = 5
So 1093064-67-5 is a valid CAS Registry Number.
1093064-67-5Relevant articles and documents
AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF A7-NICOTINIC ACETYLCHOLINE RECEPTORS
-
, (2017/01/31)
The present invention relates to novel aminobenzisoxazole compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of ot7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.
POLYCYCLIC INDAZOLE DERIVATIVES AND THEIR USE AS ERK INHIBITORS FOR THE TREATMENT OF CANCER
-
, (2009/01/24)
Disclosed are the ERK inhibitors of formula 1.0: (Chemical formula should be inserted here as it appears on abstract in paper form) and the pharmaceutically acceptable salts, esters and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.
